公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	CTLA-4 Facilitates DNA Damage–Induced Apoptosis by Interacting With PP2A	5	Front Cell Dev Biol
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	Interactions of Vank proteins from Microplitis bicoloratus bracovirus with host Dip3 suppress eIF4E expression	3	Developmental and Comparative Immunology
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury	8	Redox biology
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	Prohibitin1 facilitates viral replication by impairing the RIG-I-like receptor signaling pathway	4	In Vitro Cell Dev Biol Anim
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	The transcription factors VaERF16 and VaMYB306 interact to enhance resistance of grapevine to Botrytis cinerea infection	5	Toxicology
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	E3 ubiquitin ligase CHIP facilitates cAMP and cGMP signalling cross-talk by polyubiquitinating PDE9A.		The EMBO Journal
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	Deletion of African swine fever virus (ASFV) H240R gene attenuates the virulence of ASFV by enhancing NLRP3-mediated inflammatory responses	5	Journal of Virology
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	DIPK2A promotes STX17-and VAMP7-mediated autophagosome-lysosome fusion by binding to VAMP7B	7	Autophagy
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	ARF6 promotes Streptococcus suis suilysin induced apoptosis in HBMECs	8	Cellular Signalling
A25112	IPKine山羊抗小鼠IgG重链二抗，HRP标记 (规避轻链干扰)	Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells	7	J Exp Clin Cancer Res

首页上一页 405 406 407 408 409 410 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部